Sharapova’s stumble revives doping debate


Maria Sharapova in the quarter-final of the Australian Open  

Top-ranked Russian tennis pro Maria Sharapova has admitted that she failed a drug test at the Australian Open after taking a banned substance called mildonium (mildronate). The consequences for her career and her income are likely to be substantial.

The incident has revived the debate about the wisdom of banning more and more performance-enhancing drugs. Sharapova had been taking the drug for years for a magnesium deficiency, irregular electrical activity in the heart, and a family history of diabetes. It was only placed on the list of forbidden substances in January. Her excuse is that she overlooked an emailed warning.

But whether or not she took it deliberately, haven’t we created a bureaucratic monster, asks Oxford bioethicist Julian Savulescu. He says that “a hidden clause in WADA’s [World Anti-Doping Agency’s] code is that something will be banned if it is both performance-enhancing and artificial, either in preparation or delivery.” But is there a reasonable basis for the distinction between “natural” and “artificial”? Savulescu says No.

But what moral difference does it make whether something is natural or artificial? Outside of drugs, sport is full of artificial enhancers: running shoes are artificial, aero helmets are artificial, chlorinated swimming pools are unnatural.

Instead of taking an intuitive approach of “knowing it when we see it”, we should ban substances or practices that are clearly or probably unsafe. And we should ban specific substances that corrupt the spirit of a particular sport – that is, that substantially reduce the human element, on a sport-by-sport basis.




MORE ON THESE TOPICS | drug doping, drugs in sport, sports

This article is published by Michael Cook and BioEdge under a Creative Commons licence. You may republish it or translate it free of charge with attribution for non-commercial purposes following these guidelines. If you teach at a university we ask that your department make a donation. Commercial media must contact us for permission and fees. Some articles on this site are published under different terms.

comments powered by Disqus
 
 Search BioEdge

 Subscribe to BioEdge newsletter
rss Subscribe to BioEdge RSS feed

MOST READ

 Best of the web